Peptide 19-2.5 Inhibits Heparan Sulfate-Triggered Inflammation in Murine Cardiomyocytes Stimulated with Human Sepsis Serum
暂无分享,去创建一个
Gernot Marx | Lukas Martin | H. Haase | K. Brandenburg | G. Marx | S. Schmitz | Hajo Haase | Lena Heinbockel | Klaus Brandenburg | Sabine Doemming | Tobias Schuerholz | T. Schuerholz | L. Heinbockel | R. De Santis | Susanne Schmitz | Rebecca De Santis | Janine Hoeger | S. Doemming | L. Martin | Janine Hoeger
[1] Romain Pirracchio,et al. Should We Monitor ScVO2 in Critically Ill Patients? , 2011, Cardiology research and practice.
[2] M. Hornef,et al. The anti-inflammatory effect of the synthetic antimicrobial peptide 19-2.5 in a murine sepsis model: a prospective randomized study , 2013, Critical Care.
[3] S. Shaw,et al. The Emerging Role of TLR and Innate Immunity in Cardiovascular Disease , 2012, Cardiology research and practice.
[4] W. Knaus,et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. 1992. , 2009, Chest.
[5] C. Natanson,et al. The coronary circulation in human septic shock. , 1986, Circulation.
[6] M. Hornef,et al. New Antiseptic Peptides To Protect against Endotoxin-Mediated Shock , 2010, Antimicrobial Agents and Chemotherapy.
[7] J. Platt,et al. Conditional signaling by Toll‐like receptor 4 , 2005, The FASEB Journal.
[8] C. Parish,et al. Heparan Sulfate: A Ubiquitous Glycosaminoglycan with Multiple Roles in Immunity , 2013, Front. Immunol..
[9] I. Vlodavsky,et al. Heparin, heparan sulfate and heparanase in inflammatory reactions , 2009, Thrombosis and Haemostasis.
[10] M. Tsan,et al. Endogenous ligands of Toll‐like receptors , 2004, Journal of leukocyte biology.
[11] K. Brandenburg,et al. Antimicrobial peptides and their potential application in inflammation and sepsis , 2012, Critical Care.
[12] P. Matzinger. The Danger Model: A Renewed Sense of Self , 2002, Science.
[13] C. Parish. The role of heparan sulphate in inflammation , 2006, Nature Reviews Immunology.
[14] T. Goldmann,et al. Preclinical Investigations Reveal the Broad-Spectrum Neutralizing Activity of Peptide Pep19-2.5 on Bacterial Pathogenicity Factors , 2013, Antimicrobial Agents and Chemotherapy.
[15] R. Hancock,et al. Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies , 2006, Nature Biotechnology.
[16] M. Sallisalmi,et al. Vascular adhesion protein‐1 and syndecan‐1 in septic shock , 2012, Acta anaesthesiologica Scandinavica.
[17] Alexis Peralta,et al. Toll-like receptors are key participants in innate immune responses. , 2007, Biological research.
[18] Xiaopei Huang,et al. Heparan sulfate, an endogenous TLR4 agonist, promotes acute GVHD after allogeneic stem cell transplantation. , 2012, Blood.
[19] M. Weigand,et al. Sepsis-Induced Degradation of Endothelial Glycocalix , 2010, TheScientificWorldJournal.
[20] T. van der Poll,et al. Host innate immune responses to sepsis , 2013, Virulence.
[21] Shau-ku Huang,et al. Endotoxin contamination contributes to the in vitro cytokine-inducing activity of osteopontin preparations. , 2005, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.
[22] I. Nagaoka,et al. Antimicrobial Cathelicidin Peptide LL-37 Inhibits the LPS/ATP-Induced Pyroptosis of Macrophages by Dual Mechanism , 2014, PloS one.
[23] J. Hauber,et al. A new class of synthetic peptide inhibitors blocks attachment and entry of human pathogenic viruses. , 2012, The Journal of infectious diseases.
[24] J. Platt,et al. Receptor-Mediated Monitoring of Tissue Well-Being Via Detection of Soluble Heparan Sulfate by Toll-Like Receptor 41 , 2002, The Journal of Immunology.
[25] J. Platt,et al. Cutting Edge: An Endogenous Pathway to Systemic Inflammatory Response Syndrome (SIRS)-Like Reactions through Toll-Like Receptor 41 , 2004, The Journal of Immunology.
[26] T. Falla,et al. Antimicrobial peptides: therapeutic potential , 2006, Expert opinion on pharmacotherapy.
[27] A. Malmström,et al. TLR4 dependent heparan sulphate-induced pancreatic inflammatory response is IRF3-mediated , 2011, Journal of Translational Medicine.
[28] Sheldon Weinbaum,et al. The structure and function of the endothelial glycocalyx layer. , 2007, Annual review of biomedical engineering.
[29] G. Morelli,et al. Peptide inhibitors against herpes simplex virus infections , 2013, Journal of peptide science : an official publication of the European Peptide Society.
[30] Jinghua Chen,et al. Immunomodulatory activity of heparan sulfate mimetics from Escherichia coli K5 capsular polysaccharide in vitro. , 2015, Carbohydrate polymers.
[31] G. Horgan,et al. Relative expression software tool (REST©) for group-wise comparison and statistical analysis of relative expression results in real-time PCR , 2002 .
[32] L. MacMillan-Crow,et al. Role of Mitochondrial Oxidants in an In Vitro Model of Sepsis-Induced Renal Injury , 2012, Journal of Pharmacology and Experimental Therapeutics.
[33] M. Singer,et al. Mechanisms of sepsis-induced cardiac dysfunction , 2007, Critical care medicine.
[34] Roger C. Bone. Definitions for Sepsis and Organ Failure , 1993 .
[35] L. Moldawer,et al. ROLE OF TOLL-LIKE RECEPTORS IN THE DEVELOPMENT OF SEPSIS , 2007, Shock.
[36] S. Phipps,et al. Soluble Heparan Sulfate Fragments Generated by Heparanase Trigger the Release of Pro-Inflammatory Cytokines through TLR-4 , 2014, PloS one.
[37] K. Walley,et al. Toll-like receptor stimulation in cardiomyoctes decreases contractility and initiates an NF-kappaB dependent inflammatory response. , 2006, Cardiovascular research.
[38] N J Izzo,et al. HL-1 cells: a cardiac muscle cell line that contracts and retains phenotypic characteristics of the adult cardiomyocyte. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[39] S. Campo,et al. Glycosaminoglycans reduced inflammatory response by modulating toll-like receptor-4 in LPS-stimulated chondrocytes. , 2009, Archives of biochemistry and biophysics.
[40] B. Funke,et al. Sepsis and major abdominal surgery lead to flaking of the endothelial glycocalix. , 2011, The Journal of surgical research.
[41] M. Bodelsson,et al. Circulating glycosaminoglycan species in septic shock , 2014, Acta anaesthesiologica Scandinavica.
[42] Jay Steingrub,et al. International study of the prevalence and outcomes of infection in intensive care units , 2009 .